FDA E-News Recognizes Axiom Case Study - The FDA news item was headlined, “Axiom Case Study Yields Favorable Findings with Back Pain Device.”

June 5, 2008 — A case study concerning the Axiom Worldwide’s DRX9000, published in the 2008 issue of the European Musculoskeletal Review, was mentioned in an online newsletter from the Food and Drug Administration (FDA).

The FDA news item was headlined, “Axiom Case Study Yields Favorable Findings with Back Pain Device.”

It read, in part, “A study evaluating Axiom Worldwide’s DRX9000 true

nonsurgical spinal decompression system has produced positive results. … The study chronicled a patient who underwent 22 treatments with the device over a seven-week period and reported significant pain relief at the end of the study.”

The study can be downloaded at axiomworldwide.com/research

For more information or to receive a free report on the DRX9000 call 860-633-8756.
Visit us online at CT Spine And Disc Center.

CASE STUDY REVEALS AN INCREASE IN DISC HEIGHT AND A DECREASE IN SIZE OF A DISC HERNIATION AFTER TREATMENT WITH THE DRX9000.

The DRX9000 True Non-Surgical Spinal Decompression System was developed to provide a non-invasive option for discogenic low back pain. Researchers in a case report published in volume 2 issue 1 of the European Musculoskeletal Review state, "Evidence-based data that show the promising effects of the DRX 9000 on the safe and effective treatment of low back pain continue to accumulate." The report titled, "Management of Low-Back Pain with a Non-Surgical Decompression System (DRX9000) - Case Report" reveals the pre and post treatment MRI findings of a 69-year old male with low back pain.

Prior to treatment with the DRX9000, the patient reported experiencing lower back pain radiating in to both legs. When asked to describe his pain intensity on a scale of 0-10 (with 0 being no pain and 10 being extreme pain), the patient rated his pain level as a 10. The patient underwent 22 treatments over a seven week period. Utilizing the same pain intensity scale the patient reported a pain level of 1 post treatment. Four months after the initial visit a follow up MRI revealed decreased herniation size and increased disc height at multiple lumbar levels.

The authors conclude, "This case report further builds on previous findings that have demonstrated improvements in disc morphology after treatment with the DRX9000.